Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGB to augment CPT in veterans with PTSD
NCT05107752Phase 2Completed
- Sponsor
- The Ohio State University
- Start
- Jan 2022
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ropivacaine in post-traumatic stress disorder (PTSD), sponsored by The Ohio State University. Started Jan 2022; status: completed.
02
Drugs
ropivacaine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT05107752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05107752.